Top compounds associated with response to RASSF2


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.15 5e-05
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.0001
mRNA barasertib CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA NG-25 GDSC1000 pan-cancer AAC 0.14 0.0002
mRNA ATRA FIMM pan-cancer AAC 0.83 0.0002
mRNA Doxorubicin gCSI pan-cancer AAC 0.24 0.0002
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.54 0.0002
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.5 0.0002
Download CSV